α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
Authors
Keywords
-
Journal
BMC CANCER
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-12-28
DOI
10.1186/1471-2407-12-623
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
- (2012) Hilko Ardon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Angiogenic inhibition in high-grade gliomas: past, present and future
- (2012) Jasmin Jo et al. Expert Review of Neurotherapeutics
- Prostate cancer vaccines in clinical trials
- (2012) David M Lubaroff Expert Review of Vaccines
- Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
- (2012) Ke Sai et al. JOURNAL OF NEURO-ONCOLOGY
- Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
- (2012) Thomas Gardner et al. Human Vaccines & Immunotherapeutics
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
- (2011) Chen-Nen Chang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
- (2011) Camilo E. Fadul et al. JOURNAL OF IMMUNOTHERAPY
- Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
- (2011) Cheryl L-L Chiang et al. Journal of Translational Medicine
- Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
- (2011) B. C. McFarland et al. MOLECULAR CANCER THERAPEUTICS
- The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
- (2011) Sarah Ball et al. PLoS One
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of the expression profile of Dickkopf-1 gene in human glioma and the association with tumor malignancy
- (2010) Youxin Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
- (2010) Hilko Ardon et al. JOURNAL OF NEURO-ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells—Significant Roles of CXCL10
- (2009) Mitsugu Fujita et al. CANCER RESEARCH
- Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
- (2009) Hiroaki Ikushima et al. Cell Stem Cell
- DCVax®-Brain and DC vaccines in the treatment of GBM
- (2009) Christopher J Wheeler et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Postoperative Adjuvant Dendritic Cell-Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
- (2008) S. De Vleeschouwer et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell- and peptide-based immunotherapeutic approaches for glioma
- (2008) Ryuya Yamanaka TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started